ROSARIA TORRES: Open Payments
NPI 1467621730 · DARBY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,051 in 45 payments from 11 companies in 2025. Trend: 2023 $18 · 2024 $473 · 2025 $1,051
Food & beverage: $1,051
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $306 |
| ABBVIE INC. | 12 | $235 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $139 |
| Madrigal Pharmaceuticals | 3 | $99 |
| PFIZER INC. | 3 | $57 |
| Lilly USA, LLC | 3 | $55 |
| Ipsen Biopharmaceuticals, Inc | 2 | $51 |
| Ardelyx, Inc. | 2 | $49 |
| GENZYME CORPORATION | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: TREMFYA, REZDIFFRA, SKYRIZI, ENTYVIO, LINZESS, CREON, OMVOH, IQIRVO.
Industry payments across PA — which companies pay providers there.
